Clinical Trials › NCT05286242
Active, Not Recruiting
Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients
Sponsored by Yale University
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 400
Target enrollment
1
U.S. states
Feb 2021
Start date
Jun 2026
Expected completion
Interventions / Treatments
COVID19 vaccine
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Connecticut1 site
New Haven
MS centers in Connecticut
Compare treatment centers near a trial site by center type, providers and trials.
View Connecticut centers